Factors intrinsic and extrinsic to blood hamper the development of a routine blood test for human prion diseases Free

Abstract

Development of numerous advanced techniques in recent years have allowed detection of the pathological prion protein (PrP), the unique marker of transmissible spongiform encephalopathies (TSEs, or prion diseases), in the blood of animals and humans; however, an ante mortem screening test that can be used for the routine diagnosis of human prion diseases remains unavailable. A critical, analytical review of all the diagnostic assays developed to date will allow an evaluation of progress in this field and may facilitate the identification of the possible reasons for this delay. Thus, in this review, I provide a detailed overview of the techniques currently available for detecting PrP and other markers of the disease in blood, as well as an analysis of the significance, feasibility, reliability and application spectrum for these methods. I highlight that factors intrinsic and extrinsic to blood may interfere with the detection of PrP/prions, and that this is not yet taken into account in current tests. This may inspire researchers in this field to not only aspire to increase test sensitivity, but also to adopt other strategies in order to identify and overcome the limitations that hamper the development of a successful routine blood test for prion diseases.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.070979-0
2015-03-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/3/479.html?itemId=/content/journal/jgv/10.1099/vir.0.070979-0&mimeType=html&fmt=ahah

References

  1. Abdel-Haq H. 2012; Recent developments in cell biology: role of glycosylation in prion diseases. In Prions and Prion Diseases: New Developments pp. 85–114 Edited by Verdier J.-M. New York: Nova Science; https://www.novapublishers.com/catalog/product_info.php?products_id=43852
    [Google Scholar]
  2. Abdel-Haq H., Lu M., Cardone F., Liu Q. G., Puopolo M., Pocchiari M. 2009; Efficacy of phthalocyanine tetrasulfonate against mouse-adapted human prion strains. Arch Virol 154:1005–1007 [View Article][PubMed]
    [Google Scholar]
  3. Amorfix Life Sciences Press Release 2008; Amorfix vCJD assay achieves 100 % sensitivity and 100 % specificity on 1,000 fresh samples from UK blood donors. http://www.amorfix.com/pdf_press/pr_2008/2008_10_17_AMF_vCJD_NIBSC_Fresh_Results.pdf
    [Google Scholar]
  4. An S. S. A., Lim K. T., Oh H. J., Lee B. S., Zukic E., Ju Y. R., Yokoyama T., Kim S. Y., Welker E. 2010; Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection System. Biochem Biophys Res Commun 392:505–509 [View Article][PubMed]
    [Google Scholar]
  5. Atarashi R., Wilham J. M., Christensen L., Hughson A. G., Moore R. A., Johnson L. M., Onwubiko H. A., Priola S. A., Caughey B. 2008; Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5:211–212 [View Article][PubMed]
    [Google Scholar]
  6. Atarashi R., Satoh K., Sano K., Fuse T., Yamaguchi N., Ishibashi D., Matsubara T., Nakagaki T., Yamanaka H.other authors 2011; Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175–178 [View Article][PubMed]
    [Google Scholar]
  7. Bannach O., Birkmann E., Reinartz E., Jaeger K. E., Langeveld J. P., Rohwer R. G., Gregori L., Terry L. A., Willbold D., Riesner D. 2012; Detection of prion protein particles in blood plasma of scrapie infected sheep. PLoS ONE 7:e36620 [View Article][PubMed]
    [Google Scholar]
  8. Bannach O., Reinartz E., Henke F., Dreßen F., Oelschlegel A., Kaatz M., Groschup M. H., Willbold D., Riesner D., Birkmann E. 2013; Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases. Vet Microbiol 166:102–108 [View Article][PubMed]
    [Google Scholar]
  9. Batxelli-Molina I., Salvetat N., Andréoletti O., Guerrier L., Vicat G., Molina F., Mourton-Gilles C. 2010; Ovine serum biomarkers of early and late phase scrapie. BMC Vet Res 6:49 [View Article][PubMed]
    [Google Scholar]
  10. Bessen R. A., Marsh R. F. 1994; Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868[PubMed]
    [Google Scholar]
  11. Biasini E., Seegulam M. E., Patti B. N., Solforosi L., Medrano A. Z., Christensen H. M., Senatore A., Chiesa R., Williamson R. A., Harris D. A. 2008; Non-infectious aggregates of the prion protein react with several PrPSc-directed antibodies. J Neurochem 105:2190–2204 [View Article][PubMed]
    [Google Scholar]
  12. Biasini E., Tapella L., Mantovani S., Stravalaci M., Gobbi M., Harris D. A., Chiesa R. 2009; Immunopurification of pathological prion protein aggregates. PLoS ONE 4:e7816 [View Article][PubMed]
    [Google Scholar]
  13. Bolton D. C., McKinley M. P., Prusiner S. B. 1982; Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311 [View Article][PubMed]
    [Google Scholar]
  14. Brown P. 2001b; Creutzfeldt-Jakob disease: blood infectivity and screening tests. Semin Hematol 38:Suppl 92–6 [View Article][PubMed]
    [Google Scholar]
  15. Brown P., Rohwer R. G., Dunstan B. C., MacAuley C., Gajdusek D. C., Drohan W. N. 1998; The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38:810–816 [View Article][PubMed]
    [Google Scholar]
  16. Brown P., Cervenáková L., Diringer H. 2001a; Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 137:5–13 [View Article][PubMed]
    [Google Scholar]
  17. Castilla J., Saá P., Soto C. 2005; Detection of prions in blood. Nat Med 11:982–985[PubMed]
    [Google Scholar]
  18. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., Caughey W. S. 1991; Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30:7672–7680 [View Article][PubMed]
    [Google Scholar]
  19. Cervenakova L., Yakovleva O., McKenzie C., Kolchinsky S., McShane L., Drohan W. N., Brown P. 2003; Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 43:1687–1694 [View Article][PubMed]
    [Google Scholar]
  20. Chang B., Cheng X., Yin S., Pan T., Zhang H., Wong P., Kang S. C., Xiao F., Yan H.other authors 2007; Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals. Clin Vaccine Immunol 14:36–43 [View Article][PubMed]
    [Google Scholar]
  21. Choe L. H., Green A., Knight R. S., Thompson E. J., Lee K. H. 2002; Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease. Electrophoresis 23:2242–2246 [View Article][PubMed]
    [Google Scholar]
  22. Chohan G., Llewelyn C., Mackenzie J., Cousens S., Kennedy A., Will R., Hewitt P. 2010; Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?. Transfusion 50:1003–1006 [View Article][PubMed]
    [Google Scholar]
  23. Chung E., Prelli F., Dealler S., Lee W. S., Chang Y. T., Wisniewski T. 2011; Styryl-based and tricyclic compounds as potential anti-prion agents. PLoS ONE 6:e24844 [View Article][PubMed]
    [Google Scholar]
  24. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D. J., Alpers M. P. 2006; Kuru in the 21st century–an acquired human prion disease with very long incubation periods. Lancet 367:2068–2074 [View Article][PubMed]
    [Google Scholar]
  25. Debray H., Decout D., Strecker G., Spik G., Montreuil J. 1981; Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur J Biochem 117:41–55 [View Article][PubMed]
    [Google Scholar]
  26. Diedrich J. F., Minnigan H., Carp R. I., Whitaker J. N., Race R., Frey W. II, Haase A. T. 1991; Neuropathological changes in scrapie and Alzheimer’s disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65:4759–4768[PubMed]
    [Google Scholar]
  27. Doh-ura K., Ishikawa K., Murakami-Kubo I., Sasaki K., Mohri S., Race R., Iwaki T. 2004; Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 78:4999–5006 [View Article][PubMed]
    [Google Scholar]
  28. Edgeworth J. A., Farmer M., Sicilia A., Tavares P., Beck J., Campbell T., Lowe J., Mead S., Rudge P.other authors 2011; Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377:487–493 [View Article][PubMed]
    [Google Scholar]
  29. Edwards J. C., Moore S. J., Hawthorn J. A., Neale M. H., Terry L. A. 2010; PrP(Sc) is associated with B cells in the blood of scrapie-infected sheep. Virology 405:110–119 [View Article][PubMed]
    [Google Scholar]
  30. Elder A. M., Henderson D. M., Nalls A. V., Wilham J. M., Caughey B. W., Hoover E. A., Kincaid A. E., Bartz J. C., Mathiason C. K. 2013; In vitro detection of prionemia in TSE-infected cervids and hamsters. PLoS ONE 8:e80203 [View Article][PubMed]
    [Google Scholar]
  31. Ernoult E., Bourreau A., Gamelin E., Guette C. 2010; A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. J Biomed Biotechnol 2010:927917 [View Article][PubMed]
    [Google Scholar]
  32. European Commission DG Health and Consumer Directorate 2012; Guideline for the CE marking of blood based in vitro diagnostic medical devices for vCJD based on detection of abnormal PrP. http://ec.europa.eu/health/medical-devices/files/meddev/2_14_4_ol_en.pdf
    [Google Scholar]
  33. Forloni G., Iussich S., Awan T., Colombo L., Angeretti N., Girola L., Bertani I., Poli G., Caramelli M.other authors 2002; Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A 99:10849–10854 [View Article][PubMed]
    [Google Scholar]
  34. Gabizon R. M., McKinley M. P., Prusiner S. B. 1987; Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci U S A 84:4017–4021 [View Article][PubMed]
    [Google Scholar]
  35. Gasset M., Baldwin M. A., Fletterick R. J., Prusiner S. B. 1993; Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A 90:1–5 [View Article][PubMed]
    [Google Scholar]
  36. Gregori L., McCombie N., Palmer D., Birch P., Sowemimo-Coker S. O., Giulivi A., Rohwer R. G. 2004; Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 364:529–531 [View Article][PubMed]
    [Google Scholar]
  37. Guillaume E., Zimmermann C., Burkhard P. R., Hochstrasser D. F., Sanchez J. C. 2003; A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease. Proteomics 3:1495–1499 [View Article][PubMed]
    [Google Scholar]
  38. Guntz P., Walter C., Schosseler P., Morel P., Coste J., Cazenave J.-P. 2010; Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20 000 samples. Transfusion 50:989–995 [View Article][PubMed]
    [Google Scholar]
  39. Herzog C., Salès N., Etchegaray N., Charbonnier A., Freire S., Dormont D., Deslys J. P., Lasmézas C. I. 2004; Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363:422–428 [View Article][PubMed]
    [Google Scholar]
  40. Hewitt P. E., Llewelyn C. A., Mackenzie J., Will R. G. 2006; Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 91:221–230 [View Article][PubMed]
    [Google Scholar]
  41. Holada K., Vostal J. G., Theisen P. W., MacAuley C., Gregori L., Rohwer R. G. 2002; Scrapie infectivity in hamster blood is not associated with platelets. J Virol 76:4649–4650 [View Article][PubMed]
    [Google Scholar]
  42. Honda H., Sasaki K., Minaki H., Masui K., Suzuki S. O., Doh-Ura K., Iwaki T. 2012; Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion. Neuropathology 32:124–132 [View Article][PubMed]
    [Google Scholar]
  43. Houston F., Foster J. D., Chong A., Hunter N., Bostock C. J. 2000; Transmission of BSE by blood transfusion in sheep. Lancet 356:999–1000 [View Article][PubMed]
    [Google Scholar]
  44. Hunter N., Foster J., Chong A., McCutcheon S., Parnham D., Eaton S., MacKenzie C., Houston F. 2002; Transmission of prion diseases by blood transfusion. J Gen Virol 83:2897–2905[PubMed]
    [Google Scholar]
  45. Jackson G. S., Burk-Rafel J., Edgeworth J. A., Sicilia A., Abdilahi S., Korteweg J., Mackey J., Thomas C., Wang G.other authors 2014; Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol 71:421–428 [View Article][PubMed]
    [Google Scholar]
  46. Kocisko D. A., Lansbury P. T. Jr, Caughey B. 1996; Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 35:13434–13442 [View Article][PubMed]
    [Google Scholar]
  47. Kocisko D. A., Caughey B., Morrey J. D., Race R. E. 2006a; Enhanced antiscrapie effect using combination drug treatment. Antimicrob Agents Chemother 50:3447–3449 [View Article][PubMed]
    [Google Scholar]
  48. Kocisko D. A., Vaillant A., Lee K. S., Arnold K. M., Bertholet N., Race R. E., Olsen E. A., Juteau J. M., Caughey B. 2006b; Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother 50:1034–1044 [View Article][PubMed]
    [Google Scholar]
  49. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A.other authors 1997; Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390:74–77 [View Article][PubMed]
    [Google Scholar]
  50. Lacroux C., Vilette D., Fernández-Borges N., Litaise C., Lugan S., Morel N., Corbière F., Simon S., Simmons H.other authors 2012; Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J Virol 86:2056–2066 [View Article][PubMed]
    [Google Scholar]
  51. Lacroux C., Comoy E., Moudjou M., Perret-Liaudet A., Lugan S., Litaise C., Simmons H., Jas-Duval C., Lantier I.other authors 2014; Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog 10:e1004202 [View Article][PubMed]
    [Google Scholar]
  52. Lourenco P. C., Schmerr M. J., MacGregor I., Will R. G., Ironside J. W., Head M. W. 2006; Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease. J Gen Virol 87:3119–3124 [View Article][PubMed]
    [Google Scholar]
  53. Lukan A., Vranac T., Curin Šerbec V. 2013; TSE diagnostics: recent advances in immunoassaying prions. Clin Dev Immunol 2013:360604 [View Article][PubMed]
    [Google Scholar]
  54. Madera M., Mechref Y., Klouckova I., Novotny M. V. 2007; High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 845:121–137 [View Article][PubMed]
    [Google Scholar]
  55. Masters C. L., Richardson E. P. Jr 1978; Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101:333–344 [View Article][PubMed]
    [Google Scholar]
  56. Minor P. D. 2004; Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion. Vox Sang 86:164–170 [View Article][PubMed]
    [Google Scholar]
  57. Murayama Y., Yoshioka M., Okada H., Takata M., Yokoyama T., Mohri S. 2007; Urinary excretion and blood level of prions in scrapie-infected hamsters. J Gen Virol 88:2890–2898 [View Article][PubMed]
    [Google Scholar]
  58. Murman D. L. 2012; Early treatment of Parkinson’s disease: opportunities for managed care. Am J Manag Care 18:SupplS183–S188[PubMed]
    [Google Scholar]
  59. Oesch B., Westaway D., Wälchli M., McKinley M. P., Kent S. B., Aebersold R., Barry R. A., Tempst P., Teplow D. B.other authors 1985; A cellular gene encodes scrapie PrP 27-30 protein. Cell 40:735–746 [View Article][PubMed]
    [Google Scholar]
  60. Orrú C. D., Wilham J. M., Hughson A. G., Raymond L. D., McNally K. L., Bossers A., Ligios C., Caughey B. 2009; Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 22:515–521 [View Article][PubMed]
    [Google Scholar]
  61. Orrú C. D., Wilham J. M., Raymond L. D., Kuhn F., Schroeder B., Raeber A. J., Caughey B. 2011; Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2:e00078-11 [View Article][PubMed]
    [Google Scholar]
  62. Pan K. M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E. 1993; Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90:10962–10966 [View Article][PubMed]
    [Google Scholar]
  63. Pan T., Li R., Wong B. S., Kang S. C., Ironside J., Sy M. S. 2005a; Novel antibody-lectin enzyme-linked immunosorbent assay that distinguishes prion proteins in sporadic and variant cases of Creutzfeldt-Jakob disease. J Clin Microbiol 43:1118–1126 [View Article][PubMed]
    [Google Scholar]
  64. Pan T., Chang B., Wong P., Li C., Li R., Kang S. C., Robinson J. D., Thompsett A. R., Tein P.other authors 2005b; An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates. J Virol 79:12355–12364 [View Article][PubMed]
    [Google Scholar]
  65. Pan T., Sethi J., Nelsen C., Rudolph A., Cervenakova L., Brown P., Orser C. S. 2007; Detection of misfolded prion protein in blood with conformationally sensitive peptides. Transfusion 47:1418–1425 [View Article][PubMed]
    [Google Scholar]
  66. Prusiner S. B. 1982; Novel proteinaceous infectious particles cause scrapie. Science 216:136–144 [View Article][PubMed]
    [Google Scholar]
  67. Prusiner S. B. 1998; Prions. Proc Natl Acad Sci U S A 95:13363–13383 [View Article][PubMed]
    [Google Scholar]
  68. Relaño-Ginés A., Lehmann S., Bencsik A., Herva M. E., Torres J. M., Crozet C. A. 2011; Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner. J Infect Dis 204:1038–1045 [View Article][PubMed]
    [Google Scholar]
  69. Rubenstein R., Chang B., Gray P., Piltch M., Bulgin M. S., Sorensen-Melson S., Miller M. W. 2010; A novel method for preclinical detection of PrPSc in blood. J Gen Virol 91:1883–1892 [View Article][PubMed]
    [Google Scholar]
  70. Rudd P. M., Endo T., Colominas C., Groth D., Wheeler S. F., Harvey D. J., Wormald M. R., Serban H., Prusiner S. B.other authors 1999; Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 96:13044–13049 [View Article][PubMed]
    [Google Scholar]
  71. Ryou C., Titlow W. B., Mays C. E., Bae Y., Kim S. 2011; The suppression of prion propagation using poly-L-lysine by targeting plasminogen that stimulates prion protein conversion. Biomaterials 32:3141–3149 [View Article][PubMed]
    [Google Scholar]
  72. Saá P., Castilla J., Soto C. 2006; Presymptomatic detection of prions in blood. Science 313:92–94 [View Article][PubMed]
    [Google Scholar]
  73. Saborio G. P., Permanne B., Soto C. 2001; Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810–813 [View Article][PubMed]
    [Google Scholar]
  74. Sáez-Valero J., Fodero L. R., Sjögren M., Andreasen N., Amici S., Gallai V., Vanderstichele H., Vanmechelen E., Parnetti L.other authors 2003; Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer’s disease. J Neurosci Res 72:520–526 [View Article][PubMed]
    [Google Scholar]
  75. Segarra C., Bougard D., Moudjou M., Laude H., Béringue V., Coste J. 2013; Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection. PLoS ONE 8:e69632 [View Article][PubMed]
    [Google Scholar]
  76. Sheinerman K. S., Umansky S. R. 2013; Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7:150 [View Article][PubMed]
    [Google Scholar]
  77. Silveyra M. X., Cuadrado-Corrales N., Marcos A., Barquero M. S., Rábano A., Calero M., Sáez-Valero J. 2006; Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease. J Neurochem 96:97–104 [View Article][PubMed]
    [Google Scholar]
  78. Sim V. L. 2012; Prion disease: chemotherapeutic strategies. Infect Disord Drug Targets 12:144–160 [View Article][PubMed]
    [Google Scholar]
  79. Soto C. 2004; Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2:809–819 [View Article][PubMed]
    [Google Scholar]
  80. Talens S., Leebeek F. W., Demmers J. A., Rijken D. C. 2012; Identification of fibrin clot-bound plasma proteins. PLoS ONE 7:e41966 [View Article][PubMed]
    [Google Scholar]
  81. Tattum M. H., Jones S., Pal S., Collinge J., Jackson G. S. 2010a; Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 50:996–1002 [View Article][PubMed]
    [Google Scholar]
  82. Tattum M. H., Jones S., Pal S., Khalili-Shirazi A., Collinge J., Jackson G. S. 2010b; A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K. Transfusion 50:2619–2627 [View Article][PubMed]
    [Google Scholar]
  83. Terry L. A., Howells L., Hawthorn J., Edwards J. C., Moore S. J., Bellworthy S. J., Simmons H., Lizano S., Estey L.other authors 2009; Detection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents. J Virol 83:12552–12558 [View Article][PubMed]
    [Google Scholar]
  84. Thackray A. M., Klein M. A., Bujdoso R. 2003; Subclinical prion disease induced by oral inoculation. J Virol 77:7991–7998 [View Article][PubMed]
    [Google Scholar]
  85. Thorne L., Terry L. A. 2008; In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89:3177–3184 [View Article][PubMed]
    [Google Scholar]
  86. Triantaphyllidou I. E., Sklaviadis T., Vynios D. H. 2006; Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates. Anal Biochem 359:176–182 [View Article][PubMed]
    [Google Scholar]
  87. Trieschmann L., Navarrete Santos A., Kaschig K., Torkler S., Maas E., Schätzl H., Böhm G. 2005; Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. BMC Biotechnol 5:26 [View Article][PubMed]
    [Google Scholar]
  88. Tsukui K., Takata M., Tadokoro K. 2007; A potential blood test for transmissible spongiform encephalopathies by detecting carbohydrate-dependent aggregates of PrPres-like proteins in scrapie-infected hamster plasma. Microbiol Immunol 51:1221–1231 [View Article][PubMed]
    [Google Scholar]
  89. UK Health Protection Agency 2007; Fourth case of transfusion-associated variant-CJD infection. http://www.hpa.org.uk/hpr/archives/2007/news2007/news0307.htm#cjd [accessed Dec 24, 2010]
    [Google Scholar]
  90. Völkel D., Zimmermann K., Zerr I., Bodemer M., Lindner T., Turecek P. L., Poser S., Schwarz H. P. 2001; Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 41:441–448 [View Article][PubMed]
    [Google Scholar]
  91. Wei X., Herbst A., Ma D., Aiken J., Li L. 2011; A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome. J Proteome Res 10:2687–2702 [View Article][PubMed]
    [Google Scholar]
  92. Yakovleva O., Janiak A., McKenzie C., McShane L., Brown P., Cervenakova L. 2004; Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 44:1700–1705 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.070979-0
Loading
/content/journal/jgv/10.1099/vir.0.070979-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed